{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:54:22Z","timestamp":1791467662079,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Lanzhou Science and Technology Planning Project","award":["N0:2023-4-13"],"award-info":[{"award-number":["N0:2023-4-13"]}]},{"name":"Scientific Research Projects in the Health and Healthcare Sector of Lanzhou City","award":["A2024030"],"award-info":[{"award-number":["A2024030"]}]},{"name":"the Gansu Province Science and Technology Plan Project","award":["22JR5RA1068"],"award-info":[{"award-number":["22JR5RA1068"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Guanine nucleotide-binding protein subunit gamma-12 (GNG12), a G protein \u03b3-subunit, has been identified as a potential regulator of tumor biology. However, its functional relevance in triple-negative breast cancer (TNBC) remains unclear. In this study, we integrated pan-cancer transcriptomic analyses with experimental validation in TNBC models to investigate the expression patterns, clinicopathological significance, and biological roles of GNG12. GNG12 was found to be broadly downregulated across diverse cancer types, and its reduced expression was significantly associated with unfavorable patient survival outcomes. Low GNG12 expression correlated with adverse clinicopathological features in breast cancer (BRCA). Moreover, it was associated with poorer outcomes in TNBC patient cohorts. Functional assays demonstrated that GNG12 overexpression inhibited TNBC cell proliferation, migration, and invasion, whereas GNG12 knockdown exerted the opposite effects. Pathway analysis and western blotting indicated that GNG12 expression was associated with altered PI3K\/AKT pathway activity. Additionally, mutations at S2 and S33\u2014both located within predicted phosphorylation sites\u2014were identified as candidate regulatory alterations whose functional relevance requires further validation. Moreover, GNG12 expression was positively correlated with RNA methylation-related markers and inversely associated with promoter methylation. Taken together, GNG12 was downregulated in TNBC and associated with suppression of malignant cellular phenotypes; however, its clinical significance and mechanistic relationship with PI3K\/AKT signaling require further validation in larger cohorts and additional experimental models.<\/jats:p>","DOI":"10.1038\/s41598-026-66202-z","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:16:13Z","timestamp":1786479373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GNG12 overexpression inhibits triple-negative breast cancer cell proliferation, migration, and invasion"],"prefix":"10.1038","volume":"16","author":[{"given":"Biao-Feng","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Xu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"66202_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"66202_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","volume":"18","author":"I Soerjomataram","year":"2021","unstructured":"Soerjomataram, I. & Bray, F. Planning for tomorrow: Global cancer incidence and the role of prevention 2020-2070. Nat. Rev. Clin. Oncol. 18, 663\u2013672 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"66202_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"66202_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12013-014-0459-6","volume":"72","author":"Z Tao","year":"2015","unstructured":"Tao, Z. et al. Breast cancer: Epidemiology and etiology. Cell Biochem. Biophys. 72, 333\u2013338 (2015).","journal-title":"Cell Biochem. Biophys."},{"key":"66202_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Recent advances in therapeutic strategies for triple-negative breast cancer. J. Hematol. Oncol. 15, 121 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"66202_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00449-4","volume":"6","author":"T Tang","year":"2021","unstructured":"Tang, T. et al. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal Transduct. Target. Ther. 6, 72 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"66202_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf8399","author":"T Davoli","year":"2017","unstructured":"Davoli, T., Uno, H., Wooten, E. C. & Elledge, S. J. Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science https:\/\/doi.org\/10.1126\/science.aaf8399 (2017).","journal-title":"Science"},{"key":"66202_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707\u2013723 (2017).","journal-title":"Cell"},{"key":"66202_CR9","first-page":"45","volume":"27","author":"W Sun","year":"2019","unstructured":"Sun, W. et al. Advances in the techniques and methodologies of cancer gene therapy. Discov. Med. 27, 45\u201355 (2019).","journal-title":"Discov. Med."},{"key":"66202_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini, G., De Angelis, C., Licata, L. & Gianni, L. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat. Rev. Clin. Oncol. 19, 91\u2013113 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"66202_CR11","doi-asserted-by":"publisher","first-page":"29469","DOI":"10.1074\/jbc.270.49.29469","volume":"270","author":"R Morishita","year":"1995","unstructured":"Morishita, R. et al. Primary structure of a gamma subunit of G protein, gamma 12, and its phosphorylation by protein kinase C. J. Biol. Chem. 270, 29469\u201329475 (1995).","journal-title":"J. Biol. Chem."},{"key":"66202_CR12","doi-asserted-by":"publisher","first-page":"20512","DOI":"10.1016\/S0021-9258(20)80755-8","volume":"268","author":"T Asano","year":"1993","unstructured":"Asano, T. et al. Purification of four forms of the beta gamma subunit complex of G proteins containing different gamma subunits. J. Biol. Chem. 268, 20512\u201320519 (1993).","journal-title":"J. Biol. Chem."},{"key":"66202_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.891802","volume":"13","author":"D Wang","year":"2022","unstructured":"Wang, D. et al. Yu-Ping-Feng formula ameliorates alveolar-capillary barrier injury induced by exhausted-exercise via regulation of cytoskeleton. Front. Pharmacol. 13, 891802 (2022).","journal-title":"Front. Pharmacol."},{"key":"66202_CR14","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.bbapap.2018.08.013","volume":"1866","author":"C Luo","year":"2018","unstructured":"Luo, C., Zhao, S., Dai, W., Zheng, N. & Wang, J. Proteomic analyses reveal GNG12 regulates cell growth and casein synthesis by activating the Leu-mediated mTORC1 signaling pathway. Biochimica et Biophysica Acta (BBA) Proteins Proteomics 1866, 1092\u20131101 (2018).","journal-title":"Biochimica et Biophysica Acta (BBA) Proteins Proteomics"},{"key":"66202_CR15","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1007\/s11033-014-3448-3","volume":"41","author":"ME Babadagli","year":"2014","unstructured":"Babadagli, M. E., Tezcan, B., Yilmaz, S. T. & Tufan, A. C. Matrilin-3 as a putative effector of C-type natriuretic peptide signaling during TGF-\u03b2 induced chondrogenic differentiation of mesenchymal stem cells. Mol. Biol. Rep. 41, 5549\u20135555 (2014).","journal-title":"Mol. Biol. Rep."},{"key":"66202_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00011-009-0062-2","volume":"59","author":"KC Larson","year":"2010","unstructured":"Larson, K. C., Lipko, M., Dabrowski, M. & Draper, M. P. Gng12 is a novel negative regulator of LPS-induced inflammation in the microglial cell line BV-2. Inflamm. Res. 59, 15\u201322 (2010).","journal-title":"Inflamm. Res."},{"key":"66202_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-021-04894-2","volume":"22","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y., Shen, Y., Ding, L., Xia, S. & Jiang, L. Identification of transcription factors and construction of a novel miRNA regulatory network in primary osteoarthritis by integrated analysis. BMC Musculoskelet. Disord. 22, 1008 (2021).","journal-title":"BMC Musculoskelet. Disord."},{"key":"66202_CR18","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1177\/15353702231198068","volume":"248","author":"JR Ebert","year":"2023","unstructured":"Ebert, J. R. et al. Genome-wide association study identifying variants related to performance and injury in high-performance athletes. Exp. Biol. Med. (Maywood) 248, 1799\u20131805 (2023).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"66202_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-025-11086-3","author":"J Yang","year":"2025","unstructured":"Yang, J. et al. The role of coagulation-related genes in glioblastoma: A comprehensive analysis of the tumor microenvironment, prognosis, and treatment. Biochem. Genet. https:\/\/doi.org\/10.1007\/s10528-025-11086-3 (2025).","journal-title":"Biochem. Genet."},{"key":"66202_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s41065-024-00355-7","volume":"161","author":"S Wei","year":"2024","unstructured":"Wei, S., Zhou, J. & Dong, B. A novel risk model consisting of nine platelet-related gene signatures for predicting prognosis, immune features and drug sensitivity in glioma. Hereditas 161, 52 (2024).","journal-title":"Hereditas"},{"key":"66202_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-020-07215-4","volume":"21","author":"J Balkenhol","year":"2020","unstructured":"Balkenhol, J. et al. Comparison of the central human and mouse platelet signaling cascade by systems biological analysis. BMC Genomics 21, 897 (2020).","journal-title":"BMC Genomics"},{"key":"66202_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2023.2182169","volume":"28","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. PPARG, GNG12, and CD19 are potential independent predictors of central nerve recurrence in childhood acute lymphoblastic leukemia. Hematology 28, 2182169 (2023).","journal-title":"Hematology"},{"key":"66202_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00605-x","volume":"8","author":"CT Viet","year":"2024","unstructured":"Viet, C. T. et al. Artificial intelligence-based epigenomic, transcriptomic and histologic signatures of tobacco use in oral squamous cell carcinoma. NPJ Precis. Oncol. 8, 130 (2024).","journal-title":"NPJ Precis. Oncol."},{"key":"66202_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.758845","volume":"12","author":"J Yuan","year":"2021","unstructured":"Yuan, J. et al. Low GNG12 expression predicts adverse outcomes: A potential therapeutic target for osteosarcoma. Front. Immunol. 12, 758845 (2021).","journal-title":"Front. Immunol."},{"key":"66202_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106242","volume":"180","author":"A Alausa","year":"2022","unstructured":"Alausa, A. et al. Checkpoints and immunity in cancers: Role of GNG12. Pharmacol. Res. 180, 106242 (2022).","journal-title":"Pharmacol. Res."},{"key":"66202_CR26","first-page":"5981","volume":"13","author":"Y Lu","year":"2023","unstructured":"Lu, Y. et al. Porphyromonas gingivalis induced UCHL3 to promote colon cancer progression. Am. J. Cancer Res. 13, 5981\u20135995 (2023).","journal-title":"Am. J. Cancer Res."},{"key":"66202_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell 173, 291-304.e6 (2018).","journal-title":"Cell"},{"key":"66202_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar, D. S. et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia 25, 18\u201327 (2022).","journal-title":"Neoplasia"},{"key":"66202_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/bph.70215","author":"M Posta","year":"2025","unstructured":"Posta, M. & Gy\u0151rffy, B. Pathway-level mutational signatures predict breast cancer outcomes and reveal therapeutic targets. Br. J. Pharmacol. https:\/\/doi.org\/10.1111\/bph.70215 (2025).","journal-title":"Br. J. Pharmacol."},{"key":"66202_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).","journal-title":"Sci. Signal."},{"key":"66202_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01194-6","volume":"19","author":"H Shi","year":"2020","unstructured":"Shi, H., Chai, P., Jia, R. & Fan, X. Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation. Mol. Cancer 19, 78 (2020).","journal-title":"Mol. Cancer"},{"key":"66202_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac558","author":"CJ Liu","year":"2023","unstructured":"Liu, C. J. et al. GSCA: An integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbac558 (2023).","journal-title":"Brief Bioinform."},{"key":"66202_CR33","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45, W98-w102 (2017).","journal-title":"Nucleic Acids Res."},{"key":"66202_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011135","author":"PL Farr\u00e9","year":"2021","unstructured":"Farr\u00e9, P. L. et al. MiR-106b-5p: A master regulator of potential biomarkers for breast cancer aggressiveness and prognosis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms222011135 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"66202_CR35","first-page":"10650","volume":"10","author":"R Zhang","year":"2017","unstructured":"Zhang, R. et al. Upregulation of HOXA13 as a potential tumorigenesis and progression promoter of LUSC based on qRT-PCR and bioinformatics. Int. J. Clin. Exp. Pathol. 10, 10650\u201310665 (2017).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"66202_CR36","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/IGC.0b013e318259d8da","volume":"22","author":"J Orchel","year":"2012","unstructured":"Orchel, J. et al. Expression patterns of kinin-dependent genes in endometrial cancer. Int. J. Gynecol. Cancer 22, 937\u2013944 (2012).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"66202_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051171","author":"LJ Fennell","year":"2020","unstructured":"Fennell, L. J. et al. APC mutation marks an aggressive subtype of BRAF mutant colorectal cancers. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers12051171 (2020).","journal-title":"Cancers (Basel)"},{"key":"66202_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","volume":"20","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2020","unstructured":"Mart\u00ednez-Jim\u00e9nez, F. et al. A compendium of mutational cancer driver genes. Nat. Rev. Cancer 20, 555\u2013572 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"66202_CR39","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41568-020-0288-4","volume":"20","author":"BA Nacev","year":"2020","unstructured":"Nacev, B. A. et al. The epigenomics of sarcoma. Nat. Rev. Cancer 20, 608\u2013623 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"66202_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119360","author":"L Ma","year":"2023","unstructured":"Ma, L. et al. The mechanism of DNA methylation and miRNA in breast cancer. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24119360 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"66202_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01849-z","volume":"10","author":"X Bai","year":"2024","unstructured":"Bai, X. et al. M6A RNA methylation in biliary tract cancer: The function roles and potential therapeutic implications. Cell Death Discov. 10, 83 (2024).","journal-title":"Cell Death Discov."},{"key":"66202_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109902","author":"H Jin","year":"2024","unstructured":"Jin, H. et al. YTHDF2 favors protumoral macrophage polarization and implies poor survival outcomes in triple negative breast cancer. iScience https:\/\/doi.org\/10.1016\/j.isci.2024.109902 (2024).","journal-title":"iScience"},{"key":"66202_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.832627","volume":"12","author":"S Ma","year":"2021","unstructured":"Ma, S. et al. A computational framework to identify biomarkers for glioma recurrence and potential drugs targeting them. Front. Genet. 12, 832627 (2021).","journal-title":"Front. Genet."},{"key":"66202_CR44","doi-asserted-by":"publisher","first-page":"610","DOI":"10.4048\/jbc.2020.23.e68","volume":"23","author":"CM Lee","year":"2020","unstructured":"Lee, C. M. et al. The impact of androgen receptor and histone deacetylase 1 expression on the prognosis of ductal carcinoma in situ. J. Breast Cancer 23, 610\u2013621 (2020).","journal-title":"J. Breast Cancer"},{"key":"66202_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24207","volume":"36","author":"F Liu","year":"2022","unstructured":"Liu, F., Duan, C. & Han, Y. Circular RNA hsa_circ_0000285 regulates the microRNA-599\/G-protein subunit gamma 12 (miR-599\/GNG12) axis to promote glioma progression. J. Clin. Lab. Anal. 36, e24207 (2022).","journal-title":"J. Clin. Lab. Anal."},{"key":"66202_CR46","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/2211-5463.12784","volume":"10","author":"J Li","year":"2020","unstructured":"Li, J. et al. GNG12 regulates PD-L1 expression by activating NF-\u03baB signaling in pancreatic ductal adenocarcinoma. FEBS Open Bio 10, 278\u2013287 (2020).","journal-title":"FEBS Open Bio"},{"key":"66202_CR47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jep.2017.09.033","volume":"211","author":"C Wu","year":"2018","unstructured":"Wu, C., Qiu, S., Liu, P., Ge, Y. & Gao, X. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K\/Akt\/mTOR pathway. J. Ethnopharmacol. 211, 89\u2013100 (2018).","journal-title":"J. Ethnopharmacol."},{"key":"66202_CR48","doi-asserted-by":"publisher","first-page":"98708","DOI":"10.18632\/oncotarget.21864","volume":"8","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. DEK promoted EMT and angiogenesis through regulating PI3K\/AKT\/mTOR pathway in triple-negative breast cancer. Oncotarget 8, 98708\u201398722 (2017).","journal-title":"Oncotarget"},{"key":"66202_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01332-8","volume":"20","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K\/AKT pathway. Mol. Cancer 20, 43 (2021).","journal-title":"Mol. Cancer"},{"key":"66202_CR50","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12031-021-01956-x","volume":"72","author":"L Li","year":"2022","unstructured":"Li, L. et al. GNG12 targeted by miR-876-5p contributes to glioma progression through the activation of the PI3K\/AKT signaling pathway. J. Mol. Neurosci. 72, 441\u2013450 (2022).","journal-title":"J. Mol. Neurosci."}],"updated-by":[{"DOI":"10.1038\/s41598-026-74922-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66202-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66202-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66202-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:59:47Z","timestamp":1791464387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66202-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["66202"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-66202-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8626202\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-74922-5","URL":"https:\/\/doi.org\/10.1038\/s41598-026-74922-5","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Second People\u2019s Hospital of Lanzhou City (approval no. lzsdermyyyxllwyh202302). Animal studies were approved by the Ethics Committee of the Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (approval no. LVRIAEC-2024-061).","order":2,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25896"}}